Author: News Room

Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) — The “Frontline Workers Training Market by Offering (Solutions (LMS, Microlearning-based Platform), Services), Mode of Learning (Online/E-learning, Offline, Blended Learning), Application, Skillset Type, Vertical and Region – Global Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. The global market for frontline workers training market is projected to grow from USD 21.9 billion in 2023 to USD 46.7 billion by 2028, at a CAGR of 16.4% during the forecast period. Frontline workers are essential to organizations, yet it encounter limited learning opportunities. Utilizing a learning management system (LMS) provides convenient training delivery. Implementing…

Read More

Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) — The “Biodegradable Plastics Market by Type (PLA, Starch Blends, PHA, Biodegradable Polyesters), End Use Industry (Packaging, Consumer Goods, Textile, Agriculture & Horticulture), and Region – Global Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. The Biodegradable plastic market is projected to reach USD 20.9 billion by 2028, at a CAGR of 21.3% from USD 7.9 billion in 2023. The combination of environmental concerns, regulatory actions, consumer demand, corporate sustainability efforts, and advancements in biodegradable plastics technology are driving the adoption and use of biodegradable plastics. Packaging application accounted for the fastest…

Read More

Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) — The “Women’s Health Diagnostics Market Size, Share & Trends Analysis Report By End-use, By Application(Cancer, Infectious Disease, Osteoporosis, Pregnancy & Fertility, Prenatal), By Region And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.The global women’s health diagnostics market size is expected to reach USD 31.4 billion by 2030 and is expected to expand at a CAGR of 7.3% from 2023 to 2030 Rising adoption of point-of-care diagnostics and growing incidence of various chronic and lifestyle diseases are among the key factors stimulating the growth of the market. Besides this,…

Read More

LONDON, Nov. 27, 2023 (GLOBE NEWSWIRE) — Momcozy, a leading brand for maternal care products, celebrates the successful wrap-up of its ‘Stand Up For Mums’ campaign. This impactful initiative included a lively stand-up comedy event held in London on November 19 and a significant online movement to honour and amplify the voices of mothers. Engaging around 8,000 mothers across the UK, the campaign highlights Momcozy’s unwavering commitment to supporting and celebrating the essence of motherhood. The Stand-Up Comedy Show: A Tribute to Mothers and Mothers-To-BeOn November 19, 2023, Momcozy organized Stand Up For Mums — a special stand-up comedy show…

Read More

Exa automates manual tasks to help enhance staff productivity, expedite patient care and maximize revenue WAYNE, N.J., Nov. 26, 2023 (GLOBE NEWSWIRE) — Approximately half of recommended patient follow-up contained in radiology reports, including incidental findings, are not acted upon and often result in missed or delayed diagnosis.1,2 Automating this process has been shown to increase patient follow-up rates, which may improve patient outcomes as well as increase adherence to additional follow-up recommendations by up to 60%.3 To address this need, Konica Minolta Healthcare introduces Exa Connect as part of the Exa® Platform. Using artificial intelligence to efficiently identify patients…

Read More

If you purchased or acquired securities in DocGo between November 8, 2022 and September 17, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/DCGO. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DocGo Inc. (“DocGo” or the “Company”) (NASDAQ: DCGO) and reminds investors of the December 26, 2023 deadline to seek the role of…

Read More

If you purchased or acquired securities in Outlook between December 29, 2022 and August 29, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/OTLK. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Outlook Therapeutics, Inc. (“Outlook” or the “Company”) (NASDAQ: OTLK) and reminds investors of the January 2, 2024 deadline to seek the role…

Read More

If you purchased or acquired securities in Farfetch between March 9, 2023 and August 17, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/FTCH. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Farfetch Limited (“Farfetch” or the “Company”) (NYSE: FTCH) and reminds investors of the December 19, 2023 deadline to seek the role of…

Read More

If you purchased or acquired securities in DLocal stock or options between May 2, 2022 and May 25, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/DLO. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DLocal Limited (“DLocal” or the “Company”) (NASDAQ: DLO) and reminds investors of the December 5, 2023 deadline to seek…

Read More

If you purchased or acquired securities in Beauty Health between May 10, 2022 and November 13, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/SKIN. There is no cost or obligation to you. NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Beauty Health Company (“Beauty Health” or the “Company”) (NASDAQ: SKIN) and reminds investors of the January 16, 2024 deadline to…

Read More